InvestorsHub Logo

H2R

Followers 42
Posts 2158
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Monday, 10/09/2017 10:04:41 AM

Monday, October 09, 2017 10:04:41 AM

Post# of 4817

With approximately 500,000 monthly prescriptions for testosterone replacement therapy drugs, about 6 million annually, the market potential for Xyosted is huge. According to Symphony Health Solutions, 2016 revenue for TRT was $2.3 billion (source: Antares Form 10K).



https://seekingalpha.com/article/4112331-antares-pharma-will-october-deliver-triple-play